MDA (4,4′-methylenedianiline) in the bedroom

At a glance

What it is

MDA is an aromatic amine — two aniline units joined by a methylene bridge — and one of the pivotal intermediates of the polyurethane industry. Its dominant use is making MDI: MDA is reacted with phosgene to produce the isocyanate, which is then reacted with polyols to make the foam in mattresses, cushions and furniture. Regulatory — US EPA hazard summary, MDA → MDI → polyurethane foams The same reaction can run in reverse under the right conditions: MDI can hydrolyse, and MDA is one of its possible breakdown products.

On hazard, MDA is well characterised. IARC places it in Group 2B, possibly carcinogenic to humans, on sufficient animal evidence (thyroid and liver tumours), and it is a potent skin and respiratory sensitiser and a liver toxin that is readily absorbed through skin. Regulatory — IARC, MDA Group 2B

How it relates to the bedroom

Upstream of your foam — and a possible breakdown product

This page is deliberately careful about its claim. MDA is, first and foremost, an occupational chemical: the documented human exposures are to workers in polyurethane and composite manufacturing, where dermal absorption after contact with contaminated surfaces is the most important route. Regulatory — ATSDR Toxicological Profile, MDA (dermal absorption the key route)

Its bedroom relevance is therefore structural, on two levels. It is the feedstock for the MDI that makes a large share of mattress and furniture foam, so it sits one step upstream of a core sleep-environment material. And because MDI can hydrolyse and MDA is a possible product, aged or moisture-exposed MDI-based foam could, in principle, liberate trace amounts — though consumer foam-residue exposure to MDA is not well documented. Inferred — MDA's bedroom link is as the MDI precursor and a possible MDI-hydrolysis product; consumer foam-residue exposure is not established, unlike the well-documented occupational dermal route

Keeping it in proportion

The honest verdict is that MDA matters mainly because of what your foam is made from and how it is made, not because you are measurably exposed to MDA from a finished mattress. Inferred — the well-evidenced exposures are occupational; the consumer pathway is plausible but undocumented It earns its place in the Atlas by completing the foam-chemistry chain (aniline → MDA → MDI → foam) and by flagging a Group 2B sensitiser that the supply chain, and any future foam-degradation research, has to account for.

The regulatory picture — worldwide

MDA is one of the more tightly controlled industrial amines, governed as a carcinogen and sensitiser.

European Union — Authorisation List. MDA is a Substance of Very High Concern on the REACH Authorisation List (Annex XIV), meaning its use requires specific authorisation — among the strongest EU controls, reserved for the most hazardous substances. Regulatory — REACH Annex XIV (Authorisation List), MDA as SVHC; EU CLP carcinogen + skin/respiratory sensitiser

United States — a dedicated OSHA standard. MDA has its own OSHA standard (29 CFR 1910.1050 / 1926.60) with a low permissible exposure limit and a skin notation, reflecting both its carcinogenicity and its dermal-absorption route. Regulatory — US OSHA MDA standard (29 CFR 1910.1050) with skin notation

Carcinogen and exposure frameworks. IARC Group 2B and US EPA probable-carcinogen status feed into hazard communication, and ATSDR documents it as a priority substance. Regulatory — IARC Group 2B; US EPA probable human carcinogen; ATSDR Toxicological Profile

Where it sits. Because exposure is occupational, the regulatory weight is on worker protection rather than consumer-product limits — which is the right reading of where MDA risk actually concentrates. Inferred — the regulatory focus on occupational controls matches the documented exposure pattern

What the research says

• IARC Group 2B. Possibly carcinogenic; thyroid/liver tumours in animals. Regulatory — IARC
• The MDI precursor. Made into MDI, then polyurethane foam. Regulatory — US EPA
• Skin-absorbed sensitiser. Dermal contact the main documented exposure route. Regulatory — ATSDR
• Possible MDI breakdown product. MDI can hydrolyse to MDA. Inferred — established MDI hydrolysis chemistry; consumer relevance undocumented

What helps reduce it

Favour low-emission, well-cured foam and FR-free construction. A fully reacted, aired mattress foam minimises any residual reactive chemistry. Inferred — complete cure and airing reduce residual reactive species in foam

This is mostly a worker-protection chemical. For consumers the practical lever is the same as for foam generally: ventilation of new foam and choosing reputable, certified products. Regulatory — occupational focus of MDA controls

What does NOT help

• Treating MDA as a confirmed mattress exposure. The evidence base is occupational; consumer foam-residue exposure is not established. Inferred
• Confusing MDA with MDI. They are different: MDA is the amine precursor/breakdown product; MDI is the reactive isocyanate in the foam. Inferred

Open research questions

• Whether MDI-based mattress foam releases measurable MDA as it ages or is exposed to moisture. Speculation
• Any real consumer dermal exposure to MDA from finished polyurethane products. Speculation
• How foam-degradation chemistry changes the amine profile of old mattresses. Speculation

Citations

1. IARC Monographs — 4,4'-Methylenedianiline. Group 2B, possibly carcinogenic; sufficient animal evidence (thyroid/liver tumours). IARC list Regulatory
2. ATSDR. Toxicological Profile for 4,4'-Methylenedianiline. MDA readily absorbed through skin; dermal contact the main exposure route; sensitiser and liver toxin. ATSDR Regulatory
3. US EPA. 4,4'-Methylenedianiline (CAS 101-77-9) Hazard Summary. Precursor to MDI → polyurethane foams; probable human carcinogen; skin/respiratory sensitiser. US EPA Regulatory

Frequently asked questions

• What is MDA?

  4,4'-Methylenedianiline (MDA) is an aromatic amine and one of the most important intermediates in the polyurethane industry: it is the compound from which MDI — the isocyanate in much of the polyurethane foam in mattresses and furniture — is manufactured. MDA is reacted with phosgene to make MDI, which is then reacted with polyols to make foam. So MDA sits one step upstream of a core bedroom material, and it is also a possible product of MDI breaking back down.

• Is MDA a carcinogen?

  Yes, probably. The International Agency for Research on Cancer classifies MDA in Group 2B, possibly carcinogenic to humans, based on sufficient evidence in experimental animals (thyroid and liver tumours) with inadequate human evidence. The US EPA likewise treats it as a probable human carcinogen. Beyond cancer, MDA is a documented skin and respiratory sensitiser and a liver toxin, and it is absorbed efficiently through the skin.

• How would it reach the bedroom?

  Two indirect ways, and this is where honesty matters: MDA is mostly an occupational and upstream chemical, not a documented foam residue at consumer levels. First, it is the feedstock for the MDI in polyurethane mattress and furniture foam, so it is upstream of that material. Second, MDI can hydrolyse — react with water — and one possible breakdown product is MDA, so aged or moisture-exposed MDI-based foam could in principle release small amounts. The well-documented MDA exposures are occupational (skin contact in foam and composite manufacturing), not bedroom-level.

• How is it regulated?

  Tightly, as a hazardous industrial chemical. MDA is on the REACH Authorisation List (Annex XIV) as a Substance of Very High Concern in the EU, meaning its use requires specific authorisation; it has an EU CLP harmonised classification as a carcinogen and skin/respiratory sensitiser; and in the US it has a specific OSHA standard with a low permissible exposure limit and a skin notation. These controls are aimed at workers, reflecting that occupational dermal contact is the dominant exposure.

Related compounds

• MDI — the isocyanate MDA is made into; the actual reactive species in polyurethane foam
• Aniline — the simpler aromatic amine upstream of MDA in the foam chain
• TDI — the other major polyurethane-foam isocyanate
• View the Industrial Reactive Compounds family → — the foam-chemistry building blocks

Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress. This page is informational and is not medical advice.

Last reviewed 2026-06-29. If you find a factual error, contact us.